LH Stock Analysis: Buy, Sell, or Hold?
LH - Labcorp Holdings Inc.
$271.52
1.71 (0.63%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 17, 2026
16d
Get Alerted When LH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LH shows positive signals but monitor for confirmation. Market pricing in 1.2% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: LH shows positive signals but monitor for confirmation. Market pricing in 1.2% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$341.18
Based on 5.6% avg growth
INTRINSIC VALUE TODAY
$211.85
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LH is currently trading at $271.52, which is considered extended relative to its 30-day fair value range of $252.30 to $268.35. The stock's valuation (Forward PE: 15.4) is in line with its historical norms (14.8). At these levels, the market is pricing in 1.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LH is in a downtrend. The price is currently testing key support at $264.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $300.06 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LH is in a downtrend. The price is currently testing key support at $264.80. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $300.06 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$252.30 -
$268.35
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($300.06)
- NEUTRAL: Market pricing in 1.2% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$252.30 -
$268.35
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$9.67
(3.6%)
Support & Resistance Levels
Support Level
$264.80
Resistance Level
$275.37
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
15.40
Wall Street Target
$300.06
(+11.2%)
Revenue Growth (YoY)
8.6%
Earnings Growth (YoY)
56.0%
Profit Margin
6.2%
Valuation Premium vs History
+1.2% premium
PE vs Historical
15.4 vs 14.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.2%
(market-implied from PE analysis)
1-Year Target
$273.05
(+1%)
2-Year Target
$276.32
(+2%)
3-Year Target
$279.64
(+4%)
3-Yr Target (if PE normalizes)
(PE: 15→15)
PE COMPRESSION
$268.73
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 7.3%)
$482.53
(+79%)
Base:
(SPY PE: 15.4, Growth: 7.3%)
$333.24
(+24%)
Bear:
(PE: 13.1, Growth: 7.3%)
$283.26
(+5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 26.30 | Current EPS (TTM): $10.19
Bull Case
$506.91
(+87%)
Analyst growth 71.9%, PE expands to 28.9
Base Case
$460.83
(+70%)
Market implied 71.9%, PE stable at 26.3
Bear Case
$182.27
(-33%)
Severe decline -20.0%, PE contracts to 22.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Der Vaart Sandra D Van
SELL
3903 shares
2025-08-13
Adam H Schechter
SELL
5643 shares
2025-08-11
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced LH Option Strategies
Professional options setups generated by AI based on today's LH price and gamma walls.
